Diabetes

Vitamin A and a high-fat diet could lead to a high body mass index.

As the prevalence of diabetes continues to rise, the development of safer and more efficient therapeutics is increasing in importance.

Targeting a protein receptor in body fat shows promise in attacking diabetes.

Children with obesity may be 4 times more likely to develop type 2 diabetes.

Cardiovascular disease among diabetes patients drops through coordinated healthcare.

FDA issues safety warning for canagliflozin in the treatment of type 2 diabetes.

Canagliflozin (Invokana) may increase the risk of leg and foot amputations in patients with type 2 diabetes.

Top news of the day from across the health care landscape.

Pharmacists can help patients with diabetes manage glucose control.

Adherence to diabetes therapy related to the high cost of treatment.

Research demonstrates that pharmacists can make a difference for patients with diabetes.

Postbiotics observed to reduce blood glucose levels and increase insulin sensitivity in patients with diabetes.

Nonadherence in patients with diabetes adversely affects glycemic control.

How many patients does the average community pharmacist see who are nonadherent because they can't afford their medications?

Study weighs whether aflibercept (Eylea) is cost-effective compared with ranibizumab (Lucentis) in treating diabetic macular edema.

The FDA has approved an expanded indication for Tresiba to improve glycemic control in patients with diabetes as young as 1 year.

Active compounds in chili peppers and cannabinoids help calm the gut.

Diabetic patients who received non-invasive shockwave therapy for frozen shoulder had improved range of motion and diminished pain.

Ranibizumab has been prescribed to treat more than 55,000 patients with diabetic macular edema.

Patients in rural areas who have diabetes often have lower access to care and are more likely to be uninsured.

Diabetes is quickly becoming a rural problem in the United States.

Patients in rural areas who have diabetes often have lower access to care and are more likely to be uninsured, hospitalized, or poor.

Plant protein may decrease the risk of type 2 diabetes.

New biomarkers could accurately predict the risk of renal failure among patients with type 1 and type 2 diabetes.

Metformin has been a first-line oral treatment for patients with type 2 diabetes for 20-plus years.